SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-19-039738
Filing Date
2019-02-14
Accepted
2019-02-14 11:01:02
Documents
3
Group Members
COLUMBIA MANAGEMENT INVESTMENT ADVISERS, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d688022dsc13ga.htm SC 13G/A 46936
2 EX-99.I d688022dex99i.htm EX-99.I 1069
3 EX-99.II d688022dex99ii.htm EX-99.II 3696
  Complete submission text file 0001193125-19-039738.txt   53858
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Subject) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-37761 | Film No.: 19602604
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1099 AMERIPRISE FINANCIAL CENTER MINNEAPOLIS MN 55474
Business Address 1099 AMERIPRISE FINANCIAL CENTER MINNEAPOLIS MN 55474 612-671-8001
AMERIPRISE FINANCIAL INC (Filed by) CIK: 0000820027 (see all company filings)

IRS No.: 133180631 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice